Navigation Links
Aspirin deflated

A new study suggests that some people who take aspirin to beat off heart attacks may not be getting all the benefits they thought they were. Heart attacks are caused by clots. Doctors often recommend daily use of aspirin to help prevent heart attacks.//

Aspirin works by blocking the formation of thromboxane A2, a chemical in the body that makes platelets sticky and promotes blood clotting. The study found that as many as 75% of patients showed some resistance to the blood-thinning effects of aspirin. The study found that taking aspirin did not adequately block thromboxane in some people, making them 4 times more likely to die of a heart attack than those in whom aspirin works.

The researchers analyzed urine samples of 5,529 heart patients for a chemical byproduct of thromboxane. The levels of the byproduct varied substantially among the aspirin users but were still lower than they were in patients not taking aspirin at all. Researchers analyzed that aspirin did not adequately block thromboxane in some patients because of an underlying genetic mutation.
'"/>




Page: 1

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Aspirin reduces deaths
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Aspirin - a drug after one’s own hear
5. Aspirin surpasses Modern Anti-clotting Drugs
6. Night Time Aspirin Regimen Found to Reduce Blood Pressure
7. Aspirin Lowers Leukemia Risk
8. Aspirin usage linked with pancreatic cancer
9. Aspirin Found To Reduce The Risk Of Colon Cancer
10. Aspirin Induced Asthma , A Little-Known Inducer
11. Aspirin Found To Be Effective In Reducing Breast Cancer Rates
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Aspirin deflated

(Date:1/7/2009)...dical Enterprises, Inc. (BME), a cutting edge medi...rthopaedic memory metal implants, announced today ...dent and Chief Executive Officer. W. Casey Fox, P...ogy Officer and continue to focus his efforts on b...BME specializes in nitinol implants that contract ...
(Date:1/7/2009)...k for ER patients with hypoxia remains unclear , ...ng to the world,s most elevated natural laboratory...at the established medical rules about the amount ...rong. , "Some people can tolerate extremely low le... Dr. Michael P.W. Grocott, from University College...
(Date:1/7/2009)... 7 Stryker Corporation,(NYSE: SYK ) announced t...estor,conference: , , January 14, 2009 ... J.P. Morgan Healthcare Conference, San...st of the Company,s presentation will be available... For Investors page. The,presentation for the J.P...
(Date:1/7/2009)...l Foundation recently awarded two core faculty mem...thics a grant that will allow Drs. Gail Geller and...enges health professionals face while caring for c...neuromuscular diseases (LTNMD). , The concept for...he international HeartSongs Project funded by the ...
Breaking Medicine News(10 mins):Health News:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer 2Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Stryker To Present at Investor Conference 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3
...ished in the March 15, 2006 issue of CANCER, a pee... says that the risk of a //new cancer occurring in... increases to a fair degree in women diagnosed wit...he study also says that the risk of developing the...
...3 Valentine Day is assuming a new importance in I...ooming with Almost half// its population being bel...s shed off old inhibitions and embraced like never... festival of Valentine's Day despite opposition fr...
...d through an animal study that Aspartame can cause...inking four to five 20-ounce bottles of diet soda ...cause of cancers. The study would be published in ... Health Perspectives, an US government-run environ...
... to learn a new task, taking short breaks can go a...rding to a new study conducted by Massachusetts In...nd Matthew Wilson, working at the Massachusetts In...und that rats' brains 'replay' their experiences i...
Other Medicine News:Health News:Valentine Day Becoming Popular In India 2Health News:Task Learning Made Simple By Taking Short Breaks 2
(Date:1/7/2009)...Tiantan Puhua Hospital Stem Cells Center ( http://...using stem cells to effectively treat neurological...ienced additions to its medical and research staff...t capabilities for growing numbers of incoming int...e the distinguished Dr. Jiang Ping, who was named ...
(Date:1/6/2009)...sults from prior U.S., U.K. and China Trials , ,...s, Inc. (VTI), a development stage company targeti...nt has begun for a randomized, controlled, multi-c...Extracorporeal Liver Assist Device (ELAD) as a tre... under three protocols. The study is open for enro...
(Date:1/6/2009)...e/ -- In recent controlled studies conducted by Dr...ists found that the patented ingredient in Glyc,n ... ingredient to increase levels of nitric oxide (NO...trate (NOx) in human subjects. , , Nitric oxide...blood flow to the skeletal muscles. This is signi...
(Date:1/6/2009)...re-USNewswire/ -- Sequella, Inc., a clinical-stage...epidemic potential, announced today that SQ109, it...losis (TB), was the first drug approved for evalua...to Dynport Vaccine Company LLC and Quintiles Trans...stitute of Allergy and Infectious Diseases (NIAID)...
Breaking Medicine Technology:Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 1Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 2Oncolytics Biotech Inc Completes Dose Escalation in Combination REOLYSIN 28R 29 Docetaxel Trial 7068 3Surviving the revolution easier than withstanding human use and abuse 4415 1Surviving the revolution easier than withstanding human use and abuse 4415 2Surviving the revolution easier than withstanding human use and abuse 4415 3USC researchers identify alternate pathway that leads to palate development 4411 1USC researchers identify alternate pathway that leads to palate development 4411 2USC researchers identify alternate pathway that leads to palate development 4411 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM 121 an ErbB3 Antagonist 7062 3
...the CDC that none of its influenza vaccine (Fluvir...ted States for the current influenza season. In th...e anticipated American vaccine supply, medical off...gly alarmed about the scarcity of vaccine and the ...e seen if virulent new strains of flu or an abnorm...
...f rapid, easy-to-use diagnostic tests, many assays...ace to help clinicians assess dosage appropriatene...ence of drugs of abuse. Some of these products req...s are suitable for point of care use by medical pr..., Therapeutic drug monitoring measures the serum ...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4
Round, knurled handle. Overall length 120 mm. Designed for iris retraction and lens manipulation. Roughened posterior surface may be used to polish capsule.
Button shape tip, round serrated handle, dull finish, overall length 130 mm.
...n Super EX is a rigid gas lens with high oxygen pe... as hard contact lens, it can provide superior vis...nst astigmatism. The key feature of Menicon Super ...te, Siloxanylmethacrylate and methacrylic acid, wh...
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca
Medicine Products: